@GROG_StudyGroup

Compte Twitter officiel du GROG, Groupe de Recherche en Obstétrique et Gynécologie.

 France
Joined February 2022
  • Tweets19
  • Following40
  • Followers47
6Media
Migration sur Bluesky ---> grog-studygroup.bsky.social
6
Among participants receiving oxytocin in early labour, discontinuing oxytocin when the active phase is reached does not clinically or statistically significantly reduce neonatal morbidity compared with continuous oxytocin. @TheLancet @LeRayGO @audeglt pubmed.ncbi.nlm.nih.gov/3795…

Impact of discontinuing oxytocin in active labour on neonatal morbidity: an open-label, multicent...

French Ministry of Health and the Département de la Recherche Clinique et du Développement de l'Assistance Publique-Hôpitaux de Paris.

pubmed.ncbi.nlm.nih.gov
5
147
The early use of intrauterine balloon tamponade did not reduce the incidence of severe postpartum hemorrhage compared with its use after the failure of second-line uterotonic treatment and before recourse to invasive procedures @AJOG_thegray pubmed.ncbi.nlm.nih.gov/3720…

Efficacy of early intrauterine balloon tamponade for immediate postpartum hemorrhage after vaginal...

The early use of intrauterine balloon tamponade did not reduce the incidence of severe postpartum hemorrhage compared with its use after the failure of second-line uterotonic treatment and before...

pubmed.ncbi.nlm.nih.gov
2
35
Pluriannual meeting of the GROG Study Group in Paris. Great research projects in perspective. #Obstetrics #Team #Research
3
12
914
Our correspondence in The Lancet about FRENCH-ARRIVE after serious, evidence-free, and false accusation of unethical research. With the support of Ben W Mol and colleagues for the need for appropriate language in the debate on medicalisation of pregnancy.
1
5
6
988
Several members of the GROG study group are present at the 6th European Congress on Intrapartum Care to present their work #ECIC2023 #Belgrade 👏
4
223
Some of the GROG study group (Groupe de Recherche en Obstétrique et Gynécologie) members at the #SMFM23 meeting to proudly represent French research in obstetrics!
3
10
880
Arrêt de l'#oxytocine pendant la phase active du 1er stade du travail, l’essai randomisé français STOPOXY avec près de 2500 patientes incluses (1192 vs 1175) : pas de différence de morbidité néonatale, du mode d'accouchement, des indications de césarienne #SMFM2023 👏 @audeglt
8
15
2,841
Discontinuation of #oxytocin during the active first stage of #labor, the French RCT STOPOXY which included almost 2500 patients (1192 vs 1175): no difference in neonatal morbidity, mode of delivery, indications for C/S. #SMFM2023 👏 @audeglt
1
8
435
New article from the TRAAP2 Study Group : « Surgeons’ gender was not associated with maternal morbidity after a cesarean delivery ». #TRAAP2 ja.ma/3kC9Ta5 @CHUBordeaux @Epope_Inserm @GROG_StudyGroup @JAMASurgery @JAMANetwork
3
6
460
In #TwinPregnancies, the risk of severe #PostPartumHemorrhage increases from 2% for sum of twins' birthweights below 3000 grams to 9% for sum exceeding 6500g (i.e. 35% risk increase for +500g in sum of birthweigths) #JUMODA @greenjrnl @GROG_StudyGroup journals.lww.com/greenjourna…
8
11
📣 🚨 Le rapport de l’Enquête Nationale Périnatale 2021 est sorti aujourd’hui #ENP #perinatalite #grossesse #accouchement #naissances Le rapport complet est disponible sur le site enp.inserm.fr
1
26
3
40
Alternative to intensive management of the active phase of the second stage of labor: a multicenter randomized trial (PASST trial) among nulliparous women with an epidural - A, Intervention (moderate pushing) group. B, Control (intensive pushing) group. ow.ly/uVm350KZAey
10
35
Premiers résultats de l’essai BETADOSE sur une réduction de dose de 50 % du traitement anténatal par la bétaméthasone donné pour prévenir les complications de la prématurité : aphp.fr/contenu/premiers-res… @HopRobertDebre | @Inserm | @univ_paris_cite
9
16
Neonatal outcomes for women at risk of preterm delivery given half dose versus full dose of antenatal betamethasone: a randomised, multicentre, double-blind, placebo-controlled, non-inferiority trial. ⁦@TheLancet⁩ thelancet.com/journals/lance…
4
4
Among women with a multiple pregnancy and cesarean delivery, prophylactic tranexamic acid did not reduce the incidence of any blood loss-related outcomes. #TRAAP2SecondaryAnalysis @AJOG_thegray
1
3
4
pubmed.ncbi.nlm.nih.gov/3572…

Tranexamic acid for the prevention of blood loss after cesarean among women with twins: a secondary...

Among women with a multiple pregnancy and cesarean delivery, prophylactic tranexamic acid did not reduce the incidence of any blood loss-related outcomes.

pubmed.ncbi.nlm.nih.gov
Planned cesarean delivery for very preterm twins is not associated with better survival to discharge without severe neonatal morbidity than planned vaginal delivery. @greenjrnl #Preterm #TwinPregnancy #NeonatalMorbidity #JUMODA journals.lww.com/greenjourna…
2
7
Pessary use did not significantly reduce adverse neonatal outcomes in twin pregnancies with a short cervix. @AJOG_thegray #TwinPregnancy #Pessary ajog.org/article/S0002-9378(…
3
6
Load more